Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuki Kishino"'
Publikováno v:
Cancer Science
Trastuzumab deruxtecan (T‐DXd: DS‐8201a) is an anti‐human epidermal growth factor receptor 2 (HER2) Ab–drug conjugated with deruxtecan (DXd), a derivative of exatecan. The objective of this study was to characterize T‐DXd‐induced lung tox
Autor:
Yuki Kishino1 watanabe.yuki.w5@daiichisankyo.co.jp, Tomoko Hasegawa1, Takashi Yamoto2, Kazuhiko Mori2
Publikováno v:
Journal of Toxicological Sciences. 2019, Vol. 44 Issue 10, p701-709. 9p.
Autor:
Yuki Kishino1 watanabe.yuki.w5@daiichisankyo.co.jp, Tomoko Hasegawa1, Shingo Arakawa1, Yukari Shibaya1, Takashi Yamoto1, Kazuhiko Mori1
Publikováno v:
Journal of Toxicological Sciences. 2019, Vol. 44 Issue 3, p145-153. 9p.
Autor:
Takashi Yamoto, Kazuhiko Mori, Yumi Nishiya, Kyoko Watanabe, Yuki Kishino, Ayako Kato, Tomoko Hasegawa, Wataru Takasaki, Veronika Rozhnal
Publikováno v:
Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 838:37-45
We investigated the relationship between metabolic activities of cytochrome P450 (CYP) isozymes present in microsomal fractions derived from the livers of 78 donors and micronucleus induction by cyclophosphamide (CPA). Consequently, a wide inter-indi
Publikováno v:
The Journal of Toxicological Sciences. 44:145-153
A high incidence of positive results is obtained with in vitro genotoxicity tests, which do not correlate with the in vivo negative results in many cases. To address this issue, the metabolic profile of rat liver 9000 × g supernatant fraction (S9) p
Publikováno v:
The Journal of Toxicological Sciences. 44:701-709
Genotoxicity and carcinogenicity profiles of drugs occasionally vary across species due to species difference in drug metabolic profile. To clarify the effect of species differences in the metabolic profile on micronucleus induction, we conducted an